Selected article for: "cancer cell and gene regulation"

Author: Pruitt, Hawley C.; Devine, Daniel J.; Samant, Rajeev S.
Title: Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination
  • Document date: 2016_3_11
  • ID: k3vjqumq_32
    Snippet: No permanent genetic alterations of NMI expression such as mutation or deletion have been observed in cancer and many studies have identified "plastic" regulation of the NMI gene. In particular, loss of NMI in late stage breast cancer suggests that NMI is transiently down-regulated. Rostas et al. found that NMI is subject to post-transcriptional regulation by the micro-RNA 29 family in breast cancer cell lines, as well as in clinical samples. 81 .....
    Document: No permanent genetic alterations of NMI expression such as mutation or deletion have been observed in cancer and many studies have identified "plastic" regulation of the NMI gene. In particular, loss of NMI in late stage breast cancer suggests that NMI is transiently down-regulated. Rostas et al. found that NMI is subject to post-transcriptional regulation by the micro-RNA 29 family in breast cancer cell lines, as well as in clinical samples. 81 Interestingly, miR-29 targeting of the NMI transcript led to a decrease in epithelial morphology and markers, as well as an enhancement of invasive properties and these data further support the previously published observations by Devine and coworkers. 81 Moreover, it suggests that NMI regulation by miR-29 is a key event in the progression of breast cancer. Additionally, miR-29 down-regulation of NMI created a feed-forward regulatory loop promoting unrestricted Wnt signaling.

    Search related documents:
    Co phrase search for related documents
    • breast cancer and cancer observe: 1, 2, 3, 4
    • breast cancer and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
    • breast cancer and clinical sample: 1, 2, 3, 4
    • breast cancer and deletion mutation: 1
    • breast cancer and epithelial morphology: 1
    • breast cancer and feed forward: 1
    • breast cancer and late stage: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • breast cancer and late stage breast cancer: 1, 2, 3, 4, 5
    • breast cancer and NMI expression: 1, 2, 3, 4, 5, 6, 7
    • breast cancer and NMI gene: 1, 2
    • breast cancer and NMI loss: 1, 2
    • breast cancer and post transcriptional regulation: 1
    • breast cancer cell line and cancer cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • breast cancer cell line and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • breast cancer progression and cancer cell line: 1, 2
    • breast cancer progression and cell line: 1, 2, 3
    • breast cancer progression and late stage: 1
    • breast cancer progression and late stage breast cancer: 1
    • breast cancer progression and NMI expression: 1